Predictors for individual patient antibiotic treatment effect in hospitalized community- acquired pneumonia patients  A.F. Simonetti, C.H. van Werkhoven, V.A. Schweitzer, D. Viasus, J. Carratalà, D.F. Postma, J.J. Oosterheert, M.J.M. Bonten  Clinical Microbiology and Infection  Volume 23, Issue 10, Pages 774.e1-774.e7 (October 2017) DOI: 10.1016/j.cmi.2017.03.010 Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Predicted 30-day mortality at individual patient level. (a) Individual predicted 30-day mortality in a logistic regression model restricted to the significant interaction variables (age and smoking habit), comparing patients who receive β-lactam with patients who receive fluoroquinolone as empirical treatment. (b) Individual predicted 30-day mortality in a logistic regression model restricted to the significant interaction variables (age and smoking habit), comparing patients who receive β-lactam with patients who receive β-lactam + macrolide as empirical treatment. (c) Adjusted (Benjamini–Hochberg method) OR with 95% CI for 30-day mortality in different subgroups of patients, divided for their group age and smoking habit. Clinical Microbiology and Infection 2017 23, 774.e1-774.e7DOI: (10.1016/j.cmi.2017.03.010) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions